Cogent Biosciences Inc (COGT)
7.54
-0.39
(-4.92%)
USD |
NASDAQ |
May 10, 16:00
7.54
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Cash and Short Term Investments (Quarterly): 435.74M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 435.74M |
| December 31, 2023 | 265.71M |
| September 30, 2023 | 86.81M |
| June 30, 2023 | 329.40M |
| March 31, 2023 | 220.26M |
| December 31, 2022 | 259.28M |
| September 30, 2022 | 289.09M |
| June 30, 2022 | 325.56M |
| March 31, 2022 | 191.05M |
| December 31, 2021 | 219.68M |
| September 30, 2021 | 202.89M |
| June 30, 2021 | 218.10M |
| March 31, 2021 | 230.74M |
| Date | Value |
|---|---|
| December 31, 2020 | 242.19M |
| September 30, 2020 | 129.42M |
| June 30, 2020 | 21.34M |
| March 31, 2020 | 29.60M |
| December 31, 2019 | 37.42M |
| September 30, 2019 | 45.88M |
| June 30, 2019 | 55.86M |
| December 31, 2018 | 78.59M |
| September 30, 2018 | 87.12M |
| June 30, 2018 | 94.45M |
| March 31, 2018 | 32.40M |
| December 31, 2017 | 40.96M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
21.34M
Minimum
Jun 2020
435.74M
Maximum
Mar 2024
191.80M
Average
218.89M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| QuidelOrtho Corp | 167.30M |
| NeuroOne Medical Technologies Corp | 2.681M |
| Agios Pharmaceuticals Inc | 597.99M |
| Tenon Medical Inc | 2.428M |
| DIH Holding US Inc | -- |